(Q38691995)

English

Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression (English)

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

1 reference

based on heuristic

inferred from title

Alexander Schramm

8

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

10

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Gunther Hartmann

11

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

object named as

Maike Effern

5

0 references

author name string

Julian P Layer

1

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Marie T Kronmüller

2

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Thomas Quast

3

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Debby van den Boorn-Konijnenberg

4

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Daniel Hinze

6

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Kristina Althoff

7

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Frank Westermann

9

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Thomas Tüting

12

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Waldemar Kolanus

13

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Matthias Fischer

14

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Johannes Schulte

15

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Michael Hölzel

16

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

publication date

28 April 2017

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

6

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

6

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

e1320626

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC5486176/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

1 reference

Europe PubMed Central

22 June 2022

https://europepmc.org/article/PMC/5486176

based on heuristic

inferred from PubMed Central ID database lookup

Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Neoantigens encoded in the cancer genome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Discriminating self from non-self in nucleic acid sensing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

The Molecular Signatures Database (MSigDB) hallmark gene set collection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

nCounter(®) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Telomerase activation by genomic rearrangements in high-risk neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

The prognostic landscape of genes and infiltrating immune cells across human cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Subverting the adaptive immune resistance mechanism to improve clinical responses to immune checkpoint blockade therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Robust enumeration of cell subsets from tissue expression profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Overcoming T cell exhaustion in infection and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

PD-1 blockade induces responses by inhibiting adaptive immune resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Nivolumab in previously untreated melanoma without BRAF mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Mechanisms of neuroblastoma regression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

voom: Precision weights unlock linear model analysis tools for RNA-seq read counts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and Targeting by Antiviral DMXAA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Mutational heterogeneity in cancer and the search for new cancer-associated genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Neuroblastoma: developmental biology, cancer genomics and immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Species-specific detection of the antiviral small-molecule compound CMA by STING

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

The genetic landscape of high-risk neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

The connections between neural crest development and neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Targeted expression of MYCN causes neuroblastoma in transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

c-myc down-regulates class I HLA expression in human melanomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

23 June 2018

Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

31 August 2018

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

31 August 2018

Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

31 August 2018

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

31 August 2018

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

31 August 2018

Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486176

31 August 2018

Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc Analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28680756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/28680756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28680756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97

1 reference

https://pubmed.ncbi.nlm.nih.gov/28680756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/2162402X.2017.1320626

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

release_rrqk6bxdwvgadk5yyz4wsoqfbq

1 reference

https://api.fatcat.wiki/v0/release/rrqk6bxdwvgadk5yyz4wsoqfbq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 May 2018

http://europepmc.org/abstract/PMC/5486176

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38691995&oldid=1920158343"